Physicians who review patients' meds more likely to achieve health goals
the ONA take:
According to findings presented at the American College of Cardiology Scientific Sessions in San Diego, California, researchers have found that physicians who routinely review their patients' medications are more likely to improve their patients' adherence to their medications and achieve health goals.
For the study, researchers enrolled 13,026 patients within 30 days of hospitalization for acute coronary syndrome in 36 countries worldwide. Patients were followed for an average of 30 months.
Results showed that after 30 months in the trial, 94% of patients were still on aspirin, 95% were were still on statins, 85% were still taking beta-blockers, and 82% were still on an ACE inhibitor or an ARB.
The study also found that LDL goals were achieved in 42% of patients aiming for 70 mg/dL and 77% of patients targeting 100 mg/mL at baseline, which remained largely unchanged at the end of the study.
The findings suggest that patients are willing to take their medications for a long duration, thereby reducing the risk of additional cardiovascular events and improving health outcomes.
Physicians who routinely review their patients' medications are more likely to improve their adherence to their medications.
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Colorectal Cancer Rates Increased Sharply Among Generation X and Millennials
- Pneumonia Associated With Common Cold May Cause Fatal Illness in Stem Cell Transplant Recipients
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Antiperspirants/Deodorants and Breast Cancer (Fact Sheet)
- Genome Sequencing Explains Resistance to CTLA-4 and PD-1 Inhibitors in Metastatic Melanoma
- Lifestyle Choices Have Greater Influence on Colon and Rectal Cancer Risk
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
- Nasal Biomarker in Smokers Could Predict Lung Cancer
- Arm Lymphoscintigraphy After Axillary Lymph Node Dissection or Sentinel Lymph Node Biopsy in Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|